Average Co-Inventor Count = 3.24
ph-index = 67
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Diabetes Care Inc. (194 from 1,360 patents)
2. Therasense, Inc. (37 from 53 patents)
3. E. Heller & Company (19 from 19 patents)
4. The University of Texas System (9 from 5,452 patents)
5. Synagile Corporation (7 from 7 patents)
6. Other (6 from 832,891 patents)
7. Flexplay Technologies, Inc. (3 from 19 patents)
8. Fritz Biochem Gesellschaft Für Bioanalytik Mbh (1 from 1 patent)
9. Panasonic Corporation (16,453 patents)
10. Japan Science and Technology Agency (1,310 patents)
276 patents:
1. 12048530 - Method and apparatus for detecting false hypoglycemic conditions
2. 11911151 - Analyte monitoring device and methods of use
3. 11426376 - Devices for the administration of pharmaceutical suspensions
4. 11399748 - Analyte monitoring device and methods of use
5. 11363975 - Analyte monitoring device and methods of use
6. 11272867 - Analyte monitoring device and methods of use
7. 11207005 - Method and apparatus for detecting false hypoglycemic conditions
8. 11135191 - Devices for the administration of pharmaceutical suspensions
9. 11103165 - Analyte monitoring device and methods of use
10. 10968105 - Low-temperature pyrolysis of organic acid salts providing graphene rich carbons
11. 10952652 - Analyte monitoring device and methods of use
12. 10786474 - Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
13. 10588882 - Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
14. 10478108 - Analyte monitoring device and methods of use
15. 10328044 - Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use